Recently reported mechanisms underlying the anti-AD effect of rutin include regulation of tau hyperphosphorylation, inhibition of tau aggregation and tau oligomer-induced toxicity, and suppression of neuroinflammation by downregulating NF-κB pathway, and promotion of microglial uptake of extracellular tau oligomers [154]. The gene discussed is MAPT; the disease is Alzheimer disease.